VistaGen Therapeutics Inc VTGN

NAS: VTGN | ISIN: US92840H2022 3/05/2024

4,500 USD (+2,04%)

(+2,04%) 3/05/2024

Grafiek VistaGen Therapeutics Inc

Grafiek VistaGen Therapeutics Inc

1 dag1d 2,04%
1 week1w -5,66%
1 maand1m -14,93%
3 maanden3m -1,96%
6 maanden6m 32,74%
1 jaar1j 3.482,80%
5 jaar5j 713,74%

VistaGen Therapeutics Inc in het nieuws

Toon enkel gratis nieuws

17 oktober 2023 · Thinking about buying stock in Faraday Future Intelligent Electric, Processa Pharmaceuticals, ZW Data Action Technologies, Neuroone Medical Technologies, or Vistagen Therapeutics? · Persbericht

6 oktober 2023 · Thinking about buying stock in Profire Energy, Vistagen Therapeutics, OKYO Pharma, Nuscale Power, or Femasys? · Persbericht

16 maart 2021 · VistaGen Therapeutics to Participate in Upcoming Investor Conferences in March · Persbericht

11 maart 2021 · VistaGen’s PH10 Nasal Spray Demonstrates Different Mechanism of Action from Benzodiazepines in Preclinical Study · Persbericht

11 februari 2021 · VistaGen Therapeutics Reports Fiscal 2021 Third Quarter Financial Results and Provides Update on Expected Clinical Studies in Calendar 2021 · Persbericht

Profiel VistaGen Therapeutics Inc

Fabricage van farmaceutische preparaten

Gezondheidstechnologie

Werknemers: 33

Aandelen VistaGen Therapeutics Inc

Beurswaarde: 119,18 miljoen USD

Effecten: 27,03 miljoen

Beta: 5,68

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe